The enrolled patients were examined for their blood tests including liver function tests (cholesterol, total protein, albumin, globulin, total bilirubin, direct bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP)) and tumor markers (CA19–9 and CEA) before being underwent surgical resection. This evidence concerns the gene GPT and neoplasm.